Great Basin’s Ryan Ashton to Present at ROTH Conference

SALT LAKE CITY--()--Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced today that co-founder and Chief Executive Officer, Ryan Ashton, will speak at the 28th Annual ROTH Conference on March 14 at 5PM PDT. Mr. Ashton and Jeff Rona, Great Basin’s Chief Financial Officer, will also be available for one-on-one and group meetings with conference participants on March 14 and 15. To schedule a meeting, please contact oneononerequests@roth.com. More information can be found on the ROTH Capital Partners website at www.roth.com

The Company’s presentation will be available via webcast on the Investors Relations section of the Company website at www.gbscience.com beginning 15 minutes before the presentation time and will be archived for 90 days.

About Great Basin Scientific

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company’s website at www.gbscience.com.

Contacts

Media:
ICR
Kate Ottavio Kent, 203-682-8276
Kate.Ottavio-Kent@icrinc.com
or
Investor Relations:
ICR
David Clair, 646-277-1266
David.Clair@icrinc.com

Recent Stories

RSS feed for Great Basin Scientific, Inc.

Great Basin Scientific, Inc.